Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Sep 01, 2026
ARK Innovation ETF (ARKK) Advances +13% Over the Past 30 Days

ARK Innovation ETF (ARKK) Advances +13% Over the Past 30 Days

Key Takeaways

  • ARKK advanced roughly +13% over the last 30 days, rebounding from a late-July low near $70 to the mid-$80s.
  • The fund has also gained about +12% over the last quarter, extending a broader recovery in high-growth equities.
  • As an actively managed, concentrated "disruptive innovation" portfolio, ARKK amplifies swings in growth, biotechnology, and digital-asset sentiment.
  • Tesla, its largest holding, plus crypto-linked financials such as Coinbase, Robinhood, and Circle, and genomics leaders like CRISPR Therapeutics and Tempus AI were central to the move.
  • With a 0.75% expense ratio and roughly 45 holdings, ARKK remains a high-beta, non-diversified thematic vehicle.

ARK Innovation ETF (ARKK) Overview and Portfolio Exposure

ARK Innovation ETF is an actively managed exchange-traded fund sponsored by ARK Invest. It seeks long-term growth of capital by investing primarily in domestic and foreign equities tied to the theme of disruptive innovation, spanning genomics, next-generation internet, artificial intelligence, digital assets, and industrial innovation. The fund is non-diversified and typically holds roughly 40 to 50 positions, with a 0.75% net expense ratio and assets under management of approximately $6.5 billion to $7 billion.

The portfolio is concentrated in a handful of high-conviction names. TSLA (Tesla) is the largest single position, historically representing roughly 10% of assets. Other top holdings include TEM (Tempus AI), CRSP (CRISPR Therapeutics), ROKU (Roku), SHOP (Shopify), COIN (Coinbase), HOOD (Robinhood), AMD (Advanced Micro Devices), Circle Internet Group, and RBLX (Roblox). By sector, the fund's largest exposures are healthcare (roughly 28–30%), information technology (roughly 24–26%), financial services (roughly 15%), consumer cyclical (roughly 13–15%), communication services (roughly 10–12%), and industrials (roughly 5%).

This structure helps explain recent behavior: because a small number of large, high-beta growth and digital-asset-linked names dominate the portfolio, ARKK tends to move sharply whenever risk appetite shifts across the innovation complex. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

ARK Innovation ETF (ARKK) Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, ARKK advanced approximately +13%, from a closing level near $76 in late July to the mid-$80s. The move was not linear: the fund first drifted lower into late July, dipping toward $70, before staging a sustained, trend-driven recovery through August with gains building across consecutive weeks.

The quarterly picture is similar. From a mid-May closing level near $76.50, ARKK rose roughly +12% to the mid-$80s. That three-month gain reflects a broader rebound in growth and innovation-oriented equities after an earlier stretch of pressure, and it underscores the fund's tendency to deliver outsized moves in both directions during shifts in risk sentiment.

What Drove ARKK Price in the Last 30 Days

The 30-day advance was driven primarily by the fund's largest, highest-beta positions. TSLA, which carries the largest single weight in the portfolio, was a key contributor. Crypto-linked financials—COIN, HOOD, and Circle Internet Group—also played an outsized role, reflecting improved sentiment across the digital-asset ecosystem. In biotechnology and genomics, positions such as CRSP and TEM contributed to the healthcare-heavy tilt of the portfolio.

More broadly, the move coincided with a recovery in risk appetite for growth and disruptive-technology equities, which had pulled back sharply in late July. Because ARKK is non-diversified and heavily concentrated in these themes, the same dynamics that pressured the fund into its late-July low also powered the subsequent rebound. Interest-rate expectations and investor positioning across long-duration, high-multiple growth assets were central factors, since such names are especially sensitive to shifts in the discount-rate environment.

What Drove ARKK Performance Over the Last Quarter

Over the last quarter, ARKK's roughly +12% advance reflected a broader sector rotation back toward growth and innovation themes after an earlier bout of volatility. The fund's largest positions—led by Tesla, crypto-linked financials, and genomics names—recovered from their mid-year troughs, and the portfolio's concentration in these segments amplified the upside. Institutional and retail flows into thematic growth ETFs remained an important backdrop, as did the ongoing debate over the pace of monetary policy and its effect on high-multiple, longer-duration equities. The quarter's trend illustrates ARKK's structural character: a high-conviction, concentrated strategy that tends to lead in risk-on environments and lag when defensive positioning dominates.

ARKK ETF Outlook: What Investors Should Watch Next

Looking ahead, the key variables for ARKK are the same forces that have driven its recent swings. Interest-rate expectations and inflation data will remain central, given the portfolio's heavy weighting in long-duration, high-multiple growth assets. The earnings trajectory of its largest holdings—Tesla, crypto-linked financials, and genomics companies—will also matter, as will the health of the artificial-intelligence and digital-asset investment themes that anchor much of the portfolio. Sector rotation, capital flows into thematic ETFs, and any regulatory developments affecting digital assets or biotechnology could all influence the fund's path. Because ARKK is non-diversified and concentrated, investors should expect continued volatility in both directions, with performance likely to remain closely tied to shifts in overall risk appetite.

Using Tickeron’s AI Tools in My Research

In my research process, I often turn to Tickeron's AI Screener to quickly scan for holdings and compare performance metrics across similar thematic ETFs. It helps filter for momentum and volatility factors that matter most when evaluating funds like ARKK, allowing me to isolate the individual names and sectors driving recent moves more efficiently.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ARKK

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


ARKK's RSI Indicator recovers from overbought zone

The 10-day RSI Indicator for ARKK moved out of overbought territory on August 24, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 33 instances where the indicator moved out of the overbought zone. In of the 33 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 67 cases where ARKK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ARKK as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ARKK turned negative on September 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARKK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ARKK broke above its upper Bollinger Band on August 10, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

ARKK moved above its 50-day moving average on August 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ARKK crossed bullishly above the 50-day moving average on August 13, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ARKK advanced for three days, in of 300 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 241 cases where ARKK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Notable companies

The most notable companies in this group are Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), Advanced Micro Devices (NASDAQ:AMD), Deere & Company (NYSE:DE), Shopify Inc (NASDAQ:SHOP), Teradyne (NASDAQ:TER), Block Inc (NYSE:XYZ), Illumina (NASDAQ:ILMN), Roku (NASDAQ:ROKU).

Industry description

The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 65% of its assets) in domestic and foreign equity securities of companies that are relevant to the fund's investment theme of disruptive innovation. Its investments in foreign equity securities will be in both developed and emerging markets. The fund may invest in foreign securities listed on foreign exchanges as well as American Depositary Receipts (“ADRs”) and Global Depositary Receipts (“GDRs”). The fund is non-diversified.

Market Cap

The average market capitalization across the ARK Innovation ETF ETF is 192.77B. The market cap for tickers in the group ranges from 394.76M to 2.72T. AMZN holds the highest valuation in this group at 2.72T. The lowest valued company is PACB at 394.76M.

High and low price notable news

The average weekly price growth across all stocks in the ARK Innovation ETF ETF was -5%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 18%. AMD experienced the highest price growth at 10%, while PATH experienced the biggest fall at -24%.

Volume

The average weekly volume growth across all stocks in the ARK Innovation ETF ETF was 0%. For the same stocks of the ETF, the average monthly volume growth was -31% and the average quarterly volume growth was -40%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 66
Price Growth Rating: 43
SMR Rating: 71
Profit Risk Rating: 85
Seasonality Score: -23 (-100 ... +100)
View a ticker or compare two or three
ARKK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category MidCapGrowth

Profile
Details
Category
Mid-Cap Growth
Address
ARK ETF Trust155 West 19th Street, 5th FloorNew York
Phone
212-426-7040
Web
www.ark-funds.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.